Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study

Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study

Abstract Background Thiamine is a precursor of the essential coenzyme thiamine pyrophosphate required for glucose metabolism; it improves the immune system function and has shown to reduce the risk of several diseases. The role of thiamine in critically ill septic patient has been addressed in multi...

Full description

Bibliographic Details
Main Authors: Khalid Al Sulaiman, Ohoud Aljuhani, Maram Al Dossari, Asma Alshahrani, Aisha Alharbi, Rahmah Algarni, Majed Al Jeraisy, Shmeylan Al Harbi, Abdulmalik Al Katheri, Fahad Al Eidan, Abdulkareem M. Al Bekairy, Nouf Al Qahtani, Mashael Al Muqrin, Ramesh Vishwakarma, Ghassan Al Ghamdi
Format: Article
Language:English
Published: BMC 2021-06-01
Series:Critical Care
Subjects:
COVID-19
SARS-CoV-2
Thiamine
Vitamin B1
Vitamins
Critically ill
Online Access:https://doi.org/10.1186/s13054-021-03648-9

Internet

https://doi.org/10.1186/s13054-021-03648-9

Similar Items